RecruitingHeart Failure
A Multi-center, National, Open-label, Prospective Study to Evaluate the Performance of the V-Lap™ System
Eligible age
22–88 yrs
Accepts
All genders
Locations
1 state
Healthy volunteers
No
See if you qualify for this study
Answer a few quick questions about your location and health. Takes about a minute.
About this study
The objective of this study is to evaluate the safety and performance of the V-LAP System in subjects with New York Heart Association (NYHA) functional class II and III HF, irrespective of left ventricular ejection fraction.
Sponsor: Vectorious Medical Technologies Ltd.
Where it's recruiting
Massachusetts
Boston
Source: ClinicalTrials.gov · NCT06147336 · last updated 2025-05-30